FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $723,000 | -70.5% | 201,478 | -52.9% | 0.09% | -62.8% |
| Q3 2018 | $2,450,000 | -42.8% | 427,500 | -50.0% | 0.25% | -55.3% |
| Q2 2018 | $4,284,000 | -2.3% | 855,000 | 0.0% | 0.55% | -11.1% |
| Q1 2018 | $4,386,000 | -14.7% | 855,000 | 0.0% | 0.62% | -43.6% |
| Q4 2017 | $5,139,000 | +8.3% | 855,000 | 0.0% | 1.10% | +14.8% |
| Q3 2017 | $4,745,000 | +19.6% | 855,000 | 0.0% | 0.96% | -4.0% |
| Q2 2017 | $3,967,000 | -6.3% | 855,000 | 0.0% | 1.00% | -19.8% |
| Q1 2017 | $4,232,000 | -55.4% | 855,000 | 0.0% | 1.24% | -60.2% |
| Q4 2016 | $9,491,000 | +19.9% | 855,000 | 0.0% | 3.13% | +26.8% |
| Q3 2016 | $7,917,000 | – | 855,000 | – | 2.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |